Intellectual Property India Publishes Patent Application for Use Of 7-Methylxanthine, Its Derivatives, Prodrugs Or Pharmaceutically Acceptable Salts, Solvates Or Mixtures Thereof In Metabolic Disorders, Obesity And/Or Liver Diseases

MUMBAI, India, June 24 -- Intellectual Property India has published a patent application (202411094753 A) filed by Fairbrook Group Limited; and Sundeep Aurora on December 02, 2024, for Use Of 7-Methylxanthine, Its Derivatives, Prodrugs Or Pharmaceutically Acceptable Salts, Solvates Or Mixtures Thereof In Metabolic Disorders, Obesity And/Or Liver Diseases.

Inventors include Sundeep Aurora; and Neha Aurora.

The application for the patent was published on June 12, 2026, under issue no. 24/2026.

Abstract: The present disclosure provides 7-methylxanthine, its derivatives, prodrugs or pharmaceutically acceptable salts, solvates or mixtures thereof having activity as adenosine receptor modulators for the prevention or treatment of metabolic disorders, obesity and/or liver diseases, including metabolic dysfunction-associated steatohepatitis (MASH) in subjects, compositions comprising 7-methylxanthine alone or in combination with other active ingredients& method of preparation of such compositions.

Disclaimer: Curated by HT Syndication.